Strategies for biomarker development in psoriatic disease: a report from the GRAPPA 2010 annual meeting.

@article{Ritchlin2012StrategiesFB,
  title={Strategies for biomarker development in psoriatic disease: a report from the GRAPPA 2010 annual meeting.},
  author={Christopher T. Ritchlin},
  journal={The Journal of rheumatology},
  year={2012},
  volume={39 2},
  pages={423-6}
}
Psoriatic disease includes psoriasis and associated comorbidities (arthritis, uveitis, inflammatory bowel disease, cardiovascular disease, metabolic syndrome, and anxiety/depression) and is remarkably diverse in disease presentation and course. The marked heterogeneity of musculoskeletal involvement in psoriatic arthritis (PsA) presents major challenges to clinicians regarding diagnosis, risk stratification, and management. Members of the Group for Research and Assessment of Psoriasis and… CONTINUE READING